These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5397853)

  • 1. [Experimental clinical study of the treatment of patients with hearing disorders using 2,6 bis (diethanolamine) 4,8, dipyperidin pyrimido (5,4-D) pyrimidine].
    Bosch Torrent J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(165):285-8. PubMed ID: 5397853
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic evaluation of 2,6 bis(diethanolamino)-4,8-dipiperidino-pyrimido(5,4-d) pyrimidine in patients with Chagas' heart disease].
    Montenegro CI; Kuschnir E; Corcoba C
    Prensa Med Argent; 1965 Jul; 52(27):1649-55. PubMed ID: 4955205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the syntheses of sulfur containing pyrimido [5,4-d]pyrimidine derivatives. IV. The mechanism of dipyridamole formation from 4,8-dipiperidino-pyrimido [5,4-d]pyrimidine-2,6-disulfonyl dichloride and diethanolamine].
    Imai K; Kojima T; Tamazawa K; Takahashi K; Kawahara S
    Yakugaku Zasshi; 1976 May; 96(5):600-7. PubMed ID: 987191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Emergency treatment of acute myocardial infarct by means of slow intravenous infusion of a derivative of pyrimido-(5,4-d)-pyrimidine (preparation RA8)].
    Capelli F; Lotto A; Lomanto B
    Minerva Cardioangiol; 1966 Jun; 14(6):367-73. PubMed ID: 5917540
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of an alkylating derivative of dipyridamole.
    Andreani A; Bossa R; Fraccari A; Galatulas I; Ninci MA; Rambaldi M
    Anticancer Res; 1996; 16(4A):1831-3. PubMed ID: 8712709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L; Balzano I
    Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs effect on platelet survival time: comparison of two pyrimido-pyrimidine derivatives in patients with aortic or mitral replacement.
    Schbath J; Boissel JP; Mathy B; Ville D; Benveniste E; Sanchini B; Leizorovicz A; Belleville J; Dechavanne M; Maitre P
    Thromb Haemost; 1984 Feb; 51(1):45-9. PubMed ID: 6719387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic trials of a new pyrimido-pyrimidine derivative in diphtheric myocarditis].
    Borghesan Bosco A; Arena F
    Pediatria (Napoli); 1970; 78(2):276-96. PubMed ID: 5478734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Temperature and fever reducing properties of 2,6-bis(diethanolamino)--4,8-dipiperidino-pyrimido(5,4-d)pyrimidine (dipyridamol) in rabbits].
    Haan J; Penzhorn H
    Arzneimittelforschung; 1968 Jun; 18(6):752-5. PubMed ID: 5755814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of Duvadilan for hearing disorders].
    Takayasu S; Katrri S
    Jibiinkoka; 1966 Jul; 38(7):749-54. PubMed ID: 4860027
    [No Abstract]   [Full Text] [Related]  

  • 12. Aescin and troxerutin as a successful combination for the treatment of inner ear perfusion disturbances.
    Siegers CP; Syed Ali S; Tegtmeier M
    Phytomedicine; 2008 Mar; 15(3):160-3. PubMed ID: 18222671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Massive doses of BTMP (Biotamin) for neurologic hearing disorders].
    Tani I; Miyata S
    Jibiinkoka; 1966 Jul; 38(7):755-7. PubMed ID: 4860028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of angina pectoris with a new pyrimido-pyrimidine derivative, Persantin. Clinical experience with the double-blind control technic].
    ROMAN O; SAFFIE F
    Rev Med Chil; 1963 Apr; 91():273-9. PubMed ID: 13982572
    [No Abstract]   [Full Text] [Related]  

  • 15. [TREATMENT OF CORONARY INSUFFICIENCY WITH 2,6-BIS-DIETHANOLAMINO-4,8-DIPIPERIDINO-PYRIMIDO(5,4-D)PYRIMIDINE].
    DEVEYT F
    Belg Tijdschr Geneesk; 1964 Feb; 20():181-4. PubMed ID: 14139392
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hearing disorders using Cosaldon retard].
    Schwertdtfeger F
    Dtsch Med J; 1971 Feb; 22(3):87-92. PubMed ID: 5540731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tebonin treatment of hearing disorders in the elderly].
    Koeppel FW
    Munch Med Wochenschr; 1970 Nov; 112(46):2091-4. PubMed ID: 5537998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrastructural studies of the myocardium of animals treated with 2,6-bis-diethanol-amino-4,8-dipiperidino-pyrimido-5,4-pyrimidine].
    Sirigu F; Demurtas A; Pellegrini A
    Minerva Cardioangiol; 1967 Jul; 15(7):448-51. PubMed ID: 5615126
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of problems of equilibrium and hearing with Cinnarizine (R-516)].
    Albernaz PL; Ganança MM; Menon AD
    Hospital (Rio J); 1968 Sep; 74(3):789-91. PubMed ID: 5303763
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of defective hearing of neural origin with intravenous novocaine dosage].
    Lampé I; Jakabfi I; Kósa D
    HNO; 1965 Dec; 13(12):353-5. PubMed ID: 5871154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.